Ozempic vs Wegovy

Same molecule, two different labels. Here's what actually separates them — approved use, dosing, insurance, side effects, and what you'll really pay — plus the lower-cost semaglutide options available through Neuvé.

Reviewed for a general audience. Not medical advice — all prescribing decisions are made by a U.S. licensed clinician after intake.

The short answer

Ozempic

Semaglutide labeled for type 2 diabetes, dosed up to 2.0 mg weekly. Weight loss is a well-documented secondary effect, and coverage is more common when diabetes is documented.

Wegovy

The same semaglutide labeled for chronic weight management, dosed up to 2.4 mg weekly. It's the version studied specifically for weight loss — but coverage is far less predictable.

Side-by-side comparison

Both are once-weekly semaglutide injections from the same manufacturer. What changes is the label, the ceiling dose, and how insurers treat them.

Feature
Ozempic
Wegovy
Active ingredient
Semaglutide
Semaglutide
FDA-approved for
Type 2 diabetes (plus cardiovascular risk reduction)
Chronic weight management
Maximum weekly dose
2.0 mg
2.4 mg
How it's taken
Once-weekly subcutaneous injection
Once-weekly subcutaneous injection
Typical weight-loss data
Weight loss observed as a secondary effect in diabetes trials
Studied specifically for weight management at higher dosing
Insurance coverage
More often covered when type 2 diabetes is documented
Weight-management coverage is inconsistent across plans
Common side effects
Nausea, reflux, constipation, diarrhea
Nausea, reflux, constipation, diarrhea
Cash cost without coverage
Typically $1,000+/month at brand list price
Typically $1,000+/month at brand list price

Semaglutide options through Neuvé

Clinician-guided compounded semaglutide protocols — injectable or oral RDT — at a fraction of brand cash pricing.

Semaglutide Injectable Microdose
Weekly injection · microdose
New patients, first-time GLP-1 users
$179
/month
Semaglutide Injectable
Weekly injection · standard dose
Patients with prior GLP-1 experience
$219
/month
Semaglutide Oral RDT
Daily oral RDT
Needle-averse patients
$329
/month

Prices are starting-at estimates. Medication when approved, clinician consult and review, shipping, and injection supplies are included. Labs are separate when required. Compounded semaglutide is not an FDA-approved finished product and is prescribed only when clinically appropriate.

Considering tirzepatide instead?

Tirzepatide targets two receptors instead of one and often produces larger average weight loss. Compare semaglutide vs tirzepatide.

Frequently asked questions

Are Ozempic and Wegovy the same drug?

Yes. Both contain the same active ingredient, semaglutide, made by the same manufacturer. They differ in FDA-approved indication and maximum dose: Ozempic is approved for type 2 diabetes and doses up to 2.0 mg weekly, while Wegovy is approved for chronic weight management and doses up to 2.4 mg weekly.

Which is better for weight loss, Ozempic or Wegovy?

Wegovy is the version specifically approved for weight loss and reaches a slightly higher maximum dose, which is why weight-loss trials with Wegovy show larger average reductions. In practice, both work through the same mechanism and results depend on dose, adherence, nutrition, and activity.

Can I get Ozempic if I don't have diabetes?

Ozempic is FDA-approved for type 2 diabetes, so prescribing it purely for weight loss is off-label. Many clinicians instead prescribe the weight-management version or a compounded semaglutide protocol when appropriate.

What are the side effects?

The most common side effects for both are nausea, vomiting, diarrhea, constipation, and reflux, usually strongest when a dose is increased. Slow dose escalation, hydration, smaller meals, and adequate protein reduce most of it. Serious risks include pancreatitis and gallbladder disease, and both carry a boxed warning about thyroid C-cell tumors seen in rodents.

How much do Ozempic and Wegovy cost?

Brand list prices typically run above $1,000 per month without insurance coverage or a manufacturer savings program. Through Neuvé MD, clinician-guided compounded semaglutide protocols start at $179/month for the injectable microdose, while oral RDT is $329/month. Medication when approved, clinician consult and review, shipping, and injection supplies for injectable plans are included. Labs are separate when required.

Is compounded semaglutide the same as Ozempic?

Compounded semaglutide contains the same active molecule but is prepared by a licensed compounding facility rather than the brand manufacturer, and is not FDA-approved as a finished product. It is an option when clinically appropriate and is reviewed by a licensed clinician before prescribing.

Find out which GLP-1 fits you

Take the free 3-minute quiz. We'll match your history, goals, and tolerance to a clinician-guided protocol — semaglutide, tirzepatide, or something else entirely.